FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns

FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns

Source: 
Stat
snippet: 

A committee of vaccine experts voted to recommend the Food and Drug Administration approve Pfizer’s maternal RSV vaccine on Thursday, though the panel expressed some safety concerns.